Inhibition of tumor growth by NF‐κB inhibitors
Open Access
- 22 August 2006
- journal article
- review article
- Published by Wiley in Cancer Science
- Vol. 97 (10), 990-995
- https://doi.org/10.1111/j.1349-7006.2006.00285.x
Abstract
NF‐κB is a transcription factor that induces inflammatory cytokines and anti‐apoptotic proteins. NF‐κB is often constitutively activated in human cancers and leukemias, which might increase the malignant character of neoplastic diseases. Therefore, NF‐κB inhibitors might be useful as anticancer agents. Our research team designed a new NF‐κB inhibitor that is based on the structure of the antibiotic epoxyquomicin C isolated from a microorganism. The designed compound, DHMEQ, inhibited the ligand‐induced activation of NF‐κB, and it also inhibited the constitutively activated NF‐κB in cancer cells. DHMEQ is a unique inhibitor of NF‐κB that acts at the level of the nuclear translocation. It inhibited both canonical and non‐canonical NF‐κB activating pathways. It inhibited various carcinomas and leukemias in animal models without any toxicity, and might be useful as an anticancer agent. (Cancer Sci 2006; 97: 990–995)This publication has 43 references indexed in Scilit:
- Prevention of Cancer Cachexia by a Novel Nuclear Factor κB Inhibitor in Prostate CancerClinical Cancer Research, 2005
- Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, induces apoptosis in multiple myeloma cells in an IκBα-independent mannerMolecular Cancer Therapeutics, 2005
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- Inflammation and cancerNature, 2002
- Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by DehydroxymethylepoxyquinomicinPublished by Elsevier BV ,2002
- Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin CBioorganic & Medicinal Chemistry Letters, 2000
- An Allosteric Drug,o,o′-Bismyristoyl Thiamine Disulfide, Suppresses HIV-1 Replication through Prevention of Nuclear Translocation of both HIV-1 Tat and NF-κBBiochemical and Biophysical Research Communications, 1998
- Inhibition of NF-κB Activation by PanepoxydoneBiochemical and Biophysical Research Communications, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994